Drugs Made In America Acquisition DMAA
NASDAQ DMAA
$10.89 +0.01 (+0.09%)
At close: Oct 1, 2026 · 4:00 PM EDT

Drugs Made In America Acquisition (DMAA) Non Operating Income (2025 - 2026)

Updated

Drugs Made In America Acquisition (DMAA) posted Non Operating Income of $1.86 million for Q2 2026, down 23.0% from $2.42 million a year earlier.

Analysis

Drugs Made In America Acquisition (DMAA) Non Operating Income (2025 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Non Operating Income at Drugs Made In America Acquisition was $9.04 million; for FY2025, it was $8.76 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 BlackRock 164.13 Bn 110.49 Bn - 258.00 Mn
2 Spdr Gold Trust 133.82 Bn -424.18 Bn - -
3 Blackstone 84.08 Bn 79.01 Bn - -
4 Brookfield 82.97 Bn -82.41 Bn 4.47 Bn -
5 Kkr 81.05 Bn 47.53 Bn - -
6 Brookfield Asset Management 71.64 Bn 67.88 Bn - -
7 Apollo Global Management 65.67 Bn 3.35 Bn 10.56 Bn 73.00 Mn
8 Wheaton Precious Metals 61.89 Bn 57.32 Bn 687.86 Mn -
9 Franco Nevada 46.13 Bn 43.49 Bn 451.00 Mn -
10 Drugs Made In America Acquisition 335.55 Mn 335.55 Mn - 1.86 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.86 Mn
Dec 31, 2025 2.30 Mn
Sep 30, 2025 2.45 Mn
Jun 30, 2025 2.42 Mn
API Access

Drugs Made In America Acquisition Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-income&ticker=DMAA&period=max&api_key=YOUR_API_KEY